Carlos Alberto Lobato Tapia
Universidad Politecnica Metropolitana de Puebla, MexicoTitle: In silico analysis of Aloysia triphylla compounds with potential anxiolytic activity
Abstract
Anxiety disorders,
characterized by persistent worry, have a worldwide prevalence ranging from 3.8
to 25 %. The available treatments produce adverse effects in some patients. Another
treatment option is to use medicinal plants with the ability to induce states
of relaxation and tranquility, such is the case of Aloysia triphylla
(lemon verbena). Thus, the objective of this work was to determine, in
silico, the anxiolytic activity of the different compounds reported for A.
triphylla and to evaluate the pharmacokinetic behavior of those compounds
that result in better activities. The reported compounds were searched in
Google Scholar and Pubmed, once the list was obtained, they were entered in the
PASS online platform to obtain their most likely activities. Those activities
related to anxiety were chosen (Treatment for phobia disorder and GABA
transaminase inhibitor) and these compounds were evaluated for their
pharmacokinetic behavior in the ADMET Lab 2.0 server. The results show that
thirty-seven compounds had possible anxiolytic activity, of which seven
resulted with a probability above 90% and with (estimated) pharmacokinetic
parameters suitable for future administrations in preclinical and clinical
trials.
Biography
Carlos Alberto
Lobato Tapia has a PhD in Biomedical Sciences, his line of research focuses on
the search for bioactive compounds from plants, from obtaining extracts to
evaluating activities through cheminformatics tools. He has more than 8 years
of teaching experience. Likewise, he has participated as a reviewer for several
international magazines.